What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
Goh JXH, et al. Cancers (Basel). 2019 Jun 21;11(6):867. doi: 10.3390/cancers11060867. Cancers (Basel). 2019. PMID: 31234411
.